Genesco (GCO) activist group reports 8.7% stake and backs new board nominees
Rhea-AI Filing Summary
Bradley Radoff, Jumana Capital and Christopher Martin amended their Schedule 13D on Genesco, disclosing beneficial ownership of 966,479 shares, or about 8.7% of the common stock outstanding. Radoff directly holds 460,000 shares, while Jumana Capital holds 506,479 shares, with Martin deemed a beneficial owner of Jumana’s stake.
The filing updates their intentions around the company’s board. On June 8, 2026, Radoff withdrew the nominations of Glen Herrick and Kashif Molwani for election at the annual meeting, while the group began soliciting proxies to elect Westervelt (Westy) Ballard Jr. and Paula Poskon instead. The group also amended its internal agreement to remove Herrick and Molwani as parties.
Positive
- None.
Negative
- None.
Insights
Activist group holding 8.7% of Genesco shifts board slate.
The reporting group of Bradley Radoff, Jumana Capital and Christopher Martin now reports beneficial ownership of 966,479 Genesco shares, or 8.7% of shares outstanding as of May 18, 2026. This positions them as a sizable shareholder bloc.
The amendment describes a change in their board strategy: withdrawal of two prior nominees and proxy solicitation for Westervelt Ballard Jr. and Paula Poskon. An amendment to the group agreement removes the withdrawn nominees from the investor group, clarifying who is formally aligned in the campaign.
For investors, the key takeaway is that an organized shareholder group with a mid‑single‑digit stake is actively pursuing board representation through the upcoming annual meeting, which may influence Genesco’s governance direction depending on voting outcomes.